Bhumika Shah, MD

PCC
Drug Interactions Between Psychotropic Medications and Mpox Treatment
Letter to the Editor

February 15, 2024

The authors review pharmacologic interactions of Mpox treatments with psychotropic medications and antidepressants, antipsychotics, mood stabilizers, and sedatives.
, , , et al
PCC
Intravenous Ketamine vs Intranasal Esketamine for TRD
Letter to the Editor

February 13, 2024

Dr Mansuri and colleagues compare the pros and cons of IV ketamine and intranasal esketamine for treatment-resistant depression.
, , , et al
PCC
Impact of Paternal Depression on Children
Systematic Review

February 7, 2023

An association exists between paternal mental health and depressive symptoms and neurodevelopmental disorders in infants and children.
, , , et al
PCC
Letter to the Editor

February 18, 2021

In this letter to the editor, the authors reply to Kow and Hasan.
, , , et al
PCC
Commentary

July 2, 2020

In this commentary, the authors discuss the potential interactions of opioid use disorder treatments with novel COVID-19 medications.
, , , et al
PCC
Commentary

June 18, 2020

In this commentary, the authors discuss the potential interactions of ritonavir/lopinavir with psychiatric medications in the context of COVID-19.
, , , et al
PCC
Commentary

May 28, 2020

The FDA has approved remdesivir for severe COVID-19 in children and adults. This commentary reviews potential interactions of remdesivir with psychotropic medications.
, , , et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe